Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
- Ashraf, Yahya
- Mansouri, Hanane
- Laurent-Matha, Valérie
- Alcaraz, Lindsay,
- Roger, Pascal
- Guiu, Séverine
- Derocq, Danielle
- Robin, Gautier
- Michaud, Henri-Alexandre
- Delpech, Hélène
- Jarlier, Marta
- Pugnière, Martine
- Robert, Bruno
- Puel, Anthony
- Martin, Lucie
- Landomiel, Flavie
- Bourquard, Thomas
- Achour, Oussama
- Fruitier-Arnaudin, Ingrid
- Pichard, Alexandre
- Deshayes, Emmanuel
- Turtoi, Andrei
- Poupon, Anne
- Simony-Lafontaine, Joëlle
- Boissière-Michot, Florence
- Pirot, Nelly
- Bernex, Florence,
- Jacot, William
- Du Manoir, Stanislas
- Theillet, Charles
- Pouget, Jean-Pierre
- Navarro-Teulon, Isabelle
- Bonnefoy, Nathalie
- Pèlegrin, André
- Chardès, Thierry
- Martineau, Pierre
- Liaudet-Coopman, Emmanuelle
Publication date
January 2019
DOI Publisher
Springer Science and Business Media LLC Language
EnglishAbstract
International audienceBackground: Triple-negative breast cancer (TNBC) treatment is currently restricted to chemotherapy
Add to ORKG